Table of Contents
Overview
New York, NY – July 25, 2025 – The Global Animal Genetics Market Size is expected to be worth around US$ 11.7 Billion by 2033, from US$ 6.2 Billion in 2023, growing at a CAGR of 6.6% during the forecast period from 2024 to 2033.
Animal genetics has become a pivotal field, revolutionizing agriculture and veterinary medicine with breakthrough advancements. These genetic technologies are playing an essential role in improving animal breeding practices, ensuring better productivity, and addressing challenges such as disease resistance and sustainability.
The basic formation of animal genetics focuses on understanding the hereditary traits of animals, analyzing how these traits are passed from one generation to the next. By studying the DNA of animals, scientists can identify genetic markers associated with desirable characteristics, such as higher milk production in dairy cows, improved disease resistance, and enhanced growth rates in livestock.
Recent developments in genetic engineering and genomics have enabled the creation of more accurate breeding programs. These programs allow farmers and veterinarians to make informed decisions that enhance animal welfare and optimize production efficiency. Innovations like gene editing techniques, including CRISPR, have opened new doors for improving animal health, making it possible to prevent hereditary diseases before birth.
As consumer demand for sustainable and ethically sourced animal products grows, animal genetics holds the promise of minimizing the environmental impact of livestock farming. The sector is poised for further expansion, with genetic research providing a foundation for healthier animals and more sustainable agricultural practices.
Key Takeaways
- The global Animal Genetics Market is projected to reach approximately US$ 11.7 billion by 2033, growing from US$ 6.2 billion in 2023, reflecting a CAGR of 6.6%.
- In 2023, bovine genetics led the animal genetics segment, commanding more than 31.2% of the market share. The genetic material segment was primarily dominated by semen, which captured over 39.6% of the market share.
- Artificial insemination emerged as the most prevalent service in 2023, accounting for more than 32.7% of the market. Within the application segment, genetic trait testing held the largest share, comprising over 28.5% of the market.
- Animal breeding companies were the dominant end users in 2023, representing more than 40.1% of the market share.
- North America was the leading region in 2023, with a market value of US$ 1.9 billion and holding a 31.3% share of the global market.
Segmentation Analysis
- Animal Analysis: In 2023, bovine genetics led the animal genetics market, holding over 31.2% of the market share. This is driven by advancements aimed at improving milk and meat quality, alongside the focus on enhancing productivity and disease resistance. The porcine segment is expanding due to rising global demand for pork, with innovations in feed efficiency and growth rates. Poultry genetics also plays a key role, focusing on maximizing yield and disease resistance. Canine genetics is gaining traction, spurred by increasing pet ownership and breed-specific traits.
- Genetic Material Analysis: In 2023, semen dominated the genetic material market, holding over 39.6% of the market share due to widespread artificial insemination adoption in livestock breeding. This method supports elite genetic trait propagation, boosting productivity. Embryo transfer technology also plays a vital role, enabling rapid dissemination of superior traits across herds. DNA samples are crucial for identifying genetic disorders, guiding breeding decisions. Additionally, the oocytes segment is gaining interest, especially for species conservation and genetic diversity preservation via cryopreservation.
- Service Analysis: Artificial insemination held the leading position in the service segment in 2023, with over 32.7% of the market share, supporting genetic diversity and reproductive efficiency. DNA typing is essential for managing genetic data, ensuring breed certification, and preventing hereditary diseases. Gene editing technologies are reshaping the market by enabling precise genetic modifications, fostering disease-resistant breeds. Embryo transfer and IVF techniques are pivotal in spreading superior genetics across herds, while genetic disease testing ensures the health of future generations by preventing inherited disorders.
- Application Analysis: In 2023, genetic trait testing led the application segment, comprising over 28.5% of the market share. It helps breeders select desirable traits, improving productivity and animal health. Disease testing is critical for identifying genetic predispositions, enabling early interventions for better disease management. Product development focuses on improving genetic testing technologies, enhancing accuracy, and lowering costs, benefiting animal breeding and veterinary practices. Forensic testing is gaining importance in legal matters, providing DNA profiles for pedigree verification and wildlife-related disputes, with growing demand due to stricter regulations.
- End User Analysis: Animal breeding companies led the end-user segment in 2023, capturing more than 40.1% of the market share. Their investment in genetic technologies is crucial for enhancing breed quality and productivity. Veterinary hospitals and clinics leverage genetic insights for better breeding and genetic disorder management, enhancing care quality and operational efficiency. Research centers contribute to genetic studies, advancing understanding and innovation. Diagnostic labs and conservation groups play a critical role by identifying genetic disorders and supporting sustainable breeding and biodiversity conservation efforts.
Market Segments
By Animal
- Poultry
- Porcine
- Bovine
- Canine
- Other Animals
By Genetic Material
- Semen
- Embryos
- DNA Samples
- Oocytes
By Service
- Genetic Disease Testing
- DNA Typing
- Gene Editing
- Artificial Insemination
- Embryo Transfer
- In Vitro Fertilization (IVF)
By Application
- Genetic Trait Testing
- Disease Testing
- Product Development
- Forensic Testing
- Others
By End User
- Veterinary Hospitals & Clinics
- Research Centers & Academic Institutes
- Animal Breeding Companies
- Diagnostic Laboratories
- Others
Regional Analysis
In 2023, North America maintained a dominant position in the animal genetics market, securing over 31.3% of the market share, with a valuation of US$ 1.9 billion. This leadership is attributed to the region’s advanced agricultural practices, where farmers and breeders utilize cutting-edge genetic services, such as DNA sequencing, to improve breeding efficiency and livestock quality.
The adoption of biotechnological tools, including CRISPR, is widespread in North America, driving increased livestock productivity and enhanced disease resistance. These technologies contribute to improved production of meat, milk, and eggs, further solidifying the region’s market dominance.
North America also benefits from a strong research and development infrastructure, with substantial investments from both government and private sectors fueling innovation in animal genetics. This financial backing supports the development of new products and advancements in genetic testing services, allowing the region to stay ahead in the market.
The presence of major industry players in North America fosters continued innovation through extensive research and strategic partnerships. Coupled with a robust regulatory framework that ensures ethical practices and animal welfare, North America is well-positioned to maintain, if not expand, its market leadership in the coming years.
Emerging Trends
- Accelerated Genetic Gain through Genomic Selection: The rate of genetic improvement in dairy cattle has more than doubled since the introduction of genomic selection. Between 2010 and 2022, the average annual increase in net merit rose from USD 40 to USD 85, reflecting more precise breeding value estimates at younger ages.
- Massive Growth in Genotyping Volume: The accumulation of animal genotypes has expanded rapidly. By August 2022, over 6.6 million dairy cattle had been genotyped worldwide, with more than 1.13 million new submissions in 2021 alone.
- Widespread Adoption of Young Genomic Sires: Genomic testing has shifted breeding practices: by 2021, young genomic sires accounted for 71 % of inseminations in U.S. herds participating in Dairy Herd Improvement programs, underscoring trust in early DNA-based evaluations for mating decisions.
- Haplotype Analysis for Recessive Variant Discovery: Advanced haplotype-matching techniques are now routinely used to uncover harmful recessive conditions. In July 2022, nearly 200 000 animals received blended genomic evaluations that include tests for 27 specific recessive traits, such as neuropathy in Jerseys and curly calves in Ayrshires.
Use Cases
- Enhanced Breeding for Milk Production: Dairy producers have begun genotyping all heifers shortly after birth. Early genomic evaluations allow selection of top-performing animals before first lactation, contributing to a faster rollout of high-yield genetics in commercial herds. Over 6.6 million genotypes support these decisions, ensuring robust selection pools.
- Optimized Herd Management Decisions: Beyond sire selection, genomic data informs culling and mating. In 2021, 71 % of inseminations were driven by genomic evaluations, enabling producers to replace underperforming animals swiftly and to design matings that balance production, health, and genetic diversity goals.
- Targeted Disease Resistance Breeding: Identification of recessive disease variants has been integrated into standard evaluations. Gene tests for conditions like early embryonic death and skeletal disorders have enabled breeders to reduce the prevalence of these traits, improving herd health and reducing economic losses.
- Application in Beef Cattle Artificial Insemination: Although artificial insemination (AI) uptake remains lower in beef herds, genomics is beginning to play a role. In the U.S., 19 % of beef heifers were bred via AI in 2020, compared with only 7 % of cows; incorporating genotyping is expected to enhance selection of superior genetics even in extensive systems.
Conclusion
The global animal genetics market is undergoing transformative growth, driven by innovations in genomics, gene editing, and reproductive technologies. With a projected market value of US$ 11.7 billion by 2033, the sector is poised to significantly improve livestock productivity, disease resistance, and sustainability.
Key advancements such as CRISPR and genomic selection are enabling precise breeding decisions and early disease detection. North America continues to lead due to its advanced infrastructure and investment in R&D. As demand for ethically sourced animal products rises, animal genetics offers a scalable solution for efficient, responsible, and sustainable animal agriculture across both developed and emerging markets.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
